ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,384Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 1006

$1.71M Total Retail Price of All Prescriptions

Rank: 10 out of 1006

654 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 654 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

11% of this provider’s 654 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 19,380 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

33% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$73 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
FUROSEMIDE 779 708 1 6
ATORVASTATIN CALCIUM 670 527 2 5
LEVOTHYROXINE SODIUM 617 515 3 2
LISINOPRIL 612 539 4 3
WARFARIN SODIUM 503 496 5 8
METOPROLOL SUCCINATE 467 405 6 12
AMLODIPINE BESYLATE 467 439 6 4
OMEPRAZOLE 438 396 8 9
HYDROCODONE-ACETAMINOPHEN 413 190 S3 9 25
SIMVASTATIN 402 333 10 1
METOPROLOL TARTRATE 397 373 11 7
TRAZODONE HCL 380 309 12 21
DIOVAN 336 286 13 16
METFORMIN HCL 299 259 14 10
ESCITALOPRAM OXALATE 286 243 15 27
POTASSIUM CHLORIDE 283 230 16 30
CRESTOR 282 254 17 18
DONEPEZIL HCL 277 268 18 17
SERTRALINE HCL 268 230 19 19
GABAPENTIN 238 174 20 20
CYMBALTA 214 160 21 41
ZOLPIDEM TARTRATE 209 156 22 14
PRAVASTATIN SODIUM 202 176 23 15
NAMENDA 199 199 24 34
RISPERIDONE 185 163 25 40
ATENOLOL 172 172 26 13
NEXIUM 171 100 27 28
CARVEDILOL 170 155 28 36
CITALOPRAM HBR 168 159 29 24
PANTOPRAZOLE SODIUM 162 145 30 32
ADVAIR DISKUS 158 112 31 37
ALLOPURINOL 157 140 32 31
METFORMIN HCL ER 156 121 33 56
SPIRIVA 147 121 34 48
PREDNISONE 145 112 35 33
TRAMADOL HCL 141 70 36 35
AMOXICILLIN 140 117 37 156
MELOXICAM 134 96 38 67
DIGOXIN 132 132 39 52
QUETIAPINE FUMARATE 131 111 40 45
MIRTAZAPINE 128 128 41 26
SINGULAIR 127 67 42 82
RANITIDINE HCL 126 83 43 63
GLYBURIDE 125 114 R 44 65
SYNTHROID 121 84 45 42
LOSARTAN POTASSIUM 120 116 46 22
PAROXETINE HCL 117 107 47 62
AZITHROMYCIN 117 81 47 39
ZETIA 115 96 49 51
PROAIR HFA 115 70 49 64
ROPINIROLE HCL 109 73 51 154
BENICAR 103 98 52 78
FLUTICASONE PROPIONATE 100 65 53 55
OXYCODONE HCL 100 64 S2 53 54
LEVETIRACETAM 96 70 55 72
OXYCODONE-ACETAMINOPHEN 95 80 S2 56 57
METHYLPREDNISOLONE 94 85 57 148
ACETAMINOPHEN-CODEINE 94 79 S3 57 139
BUMETANIDE 93 92 59 204
CELEBREX 93 90 59 90
TAMSULOSIN HCL 91 86 61 23
LEVOFLOXACIN 89 81 62 96
FENTANYL 88 77 S2 63 74
DIOVAN HCT 87 75 64 60
LEXAPRO 86 63 65 103
VESICARE 86 61 65 163
CEPHALEXIN 85 72 67 142
GLIMEPIRIDE 85 75 67 50
AMOX TR-POTASSIUM CLAVULANATE 85 69 67 123
LIDODERM 84 80 70 66
TRICOR 84 58 70 101
FLUOXETINE HCL 83 74 72 85
MONTELUKAST SODIUM 83 48 72 125
JANUVIA 81 73 74 49
LIPITOR 81 63 74 47
CLOPIDOGREL 80 66 76 46
GLYBURIDE-METFORMIN HCL 78 78 R 77 192
VENLAFAXINE HCL ER 77 77 78 105
KLOR-CON M20 77 51 78 70
LYRICA 76 51 80 115
HYDROCHLOROTHIAZIDE 75 74 81 11
DILTIAZEM 24HR CD 73 68 82 88
IPRATROPIUM-ALBUTEROL 73 73 82 73
ISOSORBIDE MONONITRATE ER 71 70 84 59
JANUMET 71 71 84 151
OXYBUTYNIN CHLORIDE ER 71 62 84 92
DIVALPROEX SODIUM 70 46 87 53
TRILIPIX 70 37 87 185
PLAVIX 70 59 87 61
CYCLOBENZAPRINE HCL 70 25 R 87 113
SPIRONOLACTONE 69 34 91 71
EXFORGE 68 57 92 232
COMBIVENT 68 22 92 200
DILTIAZEM 24HR ER 66 53 94 126
FINASTERIDE 66 66 94 76
TRIAMTERENE-HCTZ 65 65 96 58
LACTULOSE 65 37 96 104
VYTORIN 63 63 98 145
OXYCODONE HCL-ACETAMINOPHEN 62 28 S2 99 138
NITROFURANTOIN MONO-MACRO 60 45 100 180
WELCHOL 59 56 101 222
LATANOPROST 59 59 101 192
SEROQUEL XR 59 38 101 239
AMIODARONE HCL 59 58 101 168
LISINOPRIL-HYDROCHLOROTHIAZIDE 58 52 105 38
LOVAZA 57 29 106 157
LANTUS 56 49 107 43
CLOTRIMAZOLE-BETAMETHASONE 56 49 107 111
CHLORHEXIDINE GLUCONATE 56 34 107 136
FENOFIBRATE 56 47 107 109
BENAZEPRIL HCL 55 55 111 112
MECLIZINE HCL 53 45 112 137
OLANZAPINE 53 53 112 68
CIPROFLOXACIN HCL 53 48 112 75
BUPROPION XL 52 31 115 177
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 12, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.